The Medicare for All debate surrounds the 2020 election—but is it truly understood?
Pharmacy Best Practices
Findings suggest that racemic substitution for single-enantiomer drugs offers an opportunity for savings.
Drug shortages might be decreasing, but their continued existence is urging the pharmacy industry to maintain its vigilance.
The policies and approaches healthcare leaders should promote.
What to expect for these high-dollar drugs.
The megamerger passes a federal judge’s scrutiny.
Does step therapy harm patient outcomes?
How the new rule is affecting healthcare orgs.
Coverage is one step in the right direction, but there’s another part that is crucial.
The pharmacy spend increases health systems can expect.